A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations

BACKGROUND: The potentials of circulating tumour DNA (ctDNA) have been studied for non-invasive disease monitoring in patients with targetable mutations. However, the majority of cancer patients harbour no targetable mutations. A workflow including targeted next-generation sequencing (NGS) and dropl...

Descripción completa

Detalles Bibliográficos
Autores principales: Demuth, Christina, Winther-Larsen, Anne, Madsen, Anne Tranberg, Meldgaard, Peter, Sorensen, Boe Sandahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089565/
https://www.ncbi.nlm.nih.gov/pubmed/30123427
http://dx.doi.org/10.18632/oncotarget.25779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089565/
https://www.ncbi.nlm.nih.gov/pubmed/30123427
http://dx.doi.org/10.18632/oncotarget.25779

Ejemplares similares